- 101. Globo-H-GM2-Lewis-y-MUC1-32(aa)-sTn(c)-TF(c)-Tn(c)-KLH Conjugate Vaccine
- [A heptavalent vaccine consisting of the tumor-associated carbohydrate antigens globohexaosylceramide (globo-H), GM2, Lewis-y, MUC1-32(aa), sTn(c), TF(c), and Tn(c) conjugated with keyhole limpet hemocyanin (KLH), an immunomodulator. This vaccine may induce the production of IgG and IgM antibodies and an antibody-dependent cell-mediated cytotoxicity (ADCC) against tumors expressing these antigens. (NCI04) ( NCI )] (UMLS (NCI) C1134578) =Organic Chemical; Pharmacologic Substance; Immunologic Factor
| - 151. Glucocorticoid deficiency
- [ ] (UMLS (ICD9CM) C1955741) GLUCOCORTICOID DEFICIENT;
=Disease or Syndrome |
- 102. Globo-H-GM2-Lewis-y-MUC1-32(aa)-sTn(c)-TF(c)-Tn(c)-KLH Conjugate Vaccine/QS21
- [A heptavalent vaccine comprised of Globo-H (Globo H Hexasaccharide 1), GM2, Lewis-y, MUC1-32(aa), sTn(c), TF(c), and Tn(c) antigens conjugated with Keyhole Limpet Hemocyanin, an immunomodulator, plus QS21, an immune enhancer. (NCI) ( NCI )] (UMLS (NCI) C1134579) =Therapeutic or Preventive Procedure
| - 152. glucocorticoid receptor
- [Cytoplasmic proteins that specifically bind glucocorticoids and mediate their cellular effects. The glucocorticoid receptor-glucocorticoid complex acts in the nucleus to induce transcription of DNA. Glucocorticoids were named for their actions on blood glucose concentration, but they have equally important effects on protein and fat metabolism. Cortisol is the most important example. ( MSH )] (UMLS (CSP) C0034809) =Amino Acid, Peptide, or Protein; Receptor ;
|
- 103. globose nucleus
- [ ] (UMLS (CSP) C0175489) =Body Part, Organ, or Organ Component
| - 153. Glucocorticoid Receptor
- [Widely expressed by human NR3C1 Gene (NR3 Family) as 6 isoforms, phosphorylated cytoplasmic (inactive)/hyperphosphorylated nuclear (active) Glucocorticoid Receptor contains a (N) modulating domain, a DNA-binding domain, and a (C) steroid-binding domain. Alpha-A (777-aa, 86-kDa precursor) predominates. Complexed with HSP90, HSP70, and FKBP5 or PPP5C, activate GR is transported (by dynein/FKBP4) to the nucleus and binds to target GREs as a homodimeric or heterodimeric (NR3C2/RXR) transcription factor and modulates other transcription factors to regulate blood glucose concentration, protein/fat metabolism, inflammatory responses, cell proliferation, and differentiation. GR appears to interact with NRIP1, POU2F1, POU2F2, STAT5A, STAT5B, SMARCA4, CREBBP/EP300, TADA2L, p160, NCOA2, and NCOA6. Sumoylation and BAG1 interaction inhibits transactivation. GR defects cause glucocorticoid resistance. (NCI) ( NCI )] (UMLS (NCI) C1370369) Glucocorticoid Receptor, Lymphocyte;
NR3C1;
Nuclear Receptor Subfamily 3, Group C, Member 1 =Amino Acid, Peptide, or Protein; Receptor |
- 104. globoside
- [Glycosphingolipids containing N-acetylglucosamine (paragloboside) or N-acetylgalactosamine (globoside). Globoside is the P antigen on erythrocytes and paragloboside is an intermediate in the biosynthesis of erythrocyte blood group ABH and P 1 glycosphingolipid antigens. The accumulation of globoside in tissue, due to a defect in hexosaminidases A and B, is the cause of Sandhoff disease. ( MSH )] (UMLS (CSP) C0017647) =Lipid; Biologically Active Substance ;
| - 154. Glucocorticoid Receptor-Interacting Protein-1
- [Involved in cell growth, development, and homeostasis, 292-kb human NCOA2 Gene at 8q13.2 encodes 1464-aa 159-kD transcriptional coactivator TIF2, containing N-terminal bHLH and PAS dimerization domains. Present in a complex with NCOA3, IKKA/B, IKBKG, and CREBBP histone acetyltransferase, TIF2 interacts with HIF1A, APEX, NR3C1, and perhaps NR3C2. TIF2 coactivator interacts with steroid receptor superfamily hormone binding domains in a hormone-dependent manner. Recruitment of CBP/p300 and PCAF coactivators for myogenic MYOD and MEF2 expression depends on NCOA1, NCOA2, and NCOA3. NCOA2 is also required for expression of MYOG and CDKN1A, and for myogenic differentiation. The NCOA2 bHLH/PAS and C-terminal activation domains mediate coactivation of MEF2C through its MADS box. The NCOA2 N- and C-termini interact with MYOG. (from LocusLink, Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C1411929) NCOA2;
NCoA-2;
Nuclear Receptor Coactivator 2;
Nuclear Receptor Coactivator-2;
TIF2;
TIF2/GRIP-1;
Transcriptional Intermediary Factor 2;
=Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 105. Globoside Metabolism
- [The chemical reactions and pathways involving globosides, globotetraosylceramides, ceramides containing a core structure of GalNAc-beta-(1,3)-Gal-alpha(1,4)Glc(I). Globosides are the major neutral glycosphingolipid in normal kidneys and erythrocytes. [ISBN:0198506732 "Oxford Dictionary of Biochemistry and Molecular Biology"] ( GO )] (UMLS (NCI) C1158414) Globoside Metabolism Pathway =Molecular Function
| - 155. Glucocorticoid-remediable aldosteronism
- (UMLS (ICD9CM) C1260386) GLUCRTCOD-REM ALDSTERNSM =Disease or Syndrome
|
- 106. Globular Hyaline Body
- (UMLS (NCI) C1333823) =Finding ;
| - 156. glucogenesis
- [ ] (UMLS (CSP) C0598530) =Molecular Function ;
|
- 107. globular protein
- [structural class of water-soluble, spherical, tightly coiled proteins which display a linear relationship between hydrodynamic radius and molecular weight. ( CSP )] (UMLS (CSP) C0178663) =Amino Acid, Peptide, or Protein ;
=protein structure;
| - 157. glucokinase
- [A group of enzymes that catalyzes the conversion of ATP and D-glucose to ADP and D-glucose 6-phosphate. They are found in invertebrates and microorganisms, and are highly specific for glucose. (Enzyme Nomenclature, 1992) EC 2.7.1.2. ( MSH )] (UMLS (CSP) C0017713) =Amino Acid, Peptide, or Protein; Enzyme ;
=alcohol phosphotransferase;
|
- 108. GLOBULE
- [Also called pellets or pilules, are made of pure sucrose, lactose, or other polysaccharides. They are formed into small globular masses of various sizes, and are medicated by placing them in a vial and adding the liquid drug attenuation in the proportion not less than one percent (v/w). After shaking, the medicated globules are dried at temperatures not to exceed 40 degrees Centigrade. (NCI) ( NCI )] (UMLS (NCI) C1337528) Globule Dosage Form;
Globule Dose Form =Biomedical or Dental Material; ;
| - 158. gluconate
- [hexonic acid or its salts derived from glucose by oxidation of the aldehyde group at C-1 to a carboxyl group. ( CSP )] (UMLS (CSP) C0017714) =Carbohydrate; Biologically Active Substance ;
=sugar acid;
=Calcium D-gluconate;
COPPER GLUCONATE;
GLUCONATE |
- 109. globulin
- [do not confuse with GLOBIN. ( CSP )] (UMLS (CSP) C0017649) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=blood protein;
gene product =alpha globulin;
cryoglobulin;
macroglobulin;
serum globulin;
myeloma globulin;
serum globulin;
TG | - 159. gluconeogenesis
- [biosynthesis of glucose from 3-carbon precursors, including aminoacids (this is the basis of protein breakdown during starvation). ( CSP )] (UMLS (NCI) C0017715) =Molecular Function =carbohydrate biosynthesis;
glucose metabolism |
- 110. Globus Hystericus
- (UMLS (NCI) C0017650) =Mental or Behavioral Dysfunction
| - 160. glucophage
- [ ] (UMLS (CSP) C0591573) =Organic Chemical; Pharmacologic Substance ;
|
- 111. globus pallidus
- [The representation of the phylogenetically oldest part of the corpus striatum called the paleostriatum. It forms the smaller, more medial part of the lentiform nucleus. (MeSH) ( NCI )] (UMLS (CSP) C0017651) =Body Part, Organ, or Organ Component
| - 161. Glucosamine Sulfate
- [An amino sugar (2-amino, 2-deoxyglucose) in cell membranes, Glucosamine Sulfate is believed to play a role in cartilage formation and repair. Long-term glucosamine sulfate treatment retards progression of knee osteoarthritis; the mechanism appears to involve glucosamine's role as an essential substrate for glycosaminoglycans and hyaluronic acid, needed for formation of the joint proteoglycan structural matrix. (NCI04) ( NCI )] (UMLS (NCI) C0017720) =Carbohydrate; Pharmacologic Substance ;
|
- 112. GLOBUS PALLIDUS OPS
- [ ] (UMLS (ICD9CM) C0195781) =Therapeutic or Preventive Procedure
| - 162. glucose 1 phosphatase
- [ ] (UMLS (CSP) C0061413) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 113. glomangioma
- [A morphologic variant of the glomus tumor characterized by the presence of dilated veins, surrounded by small clusters of glomus cells. Glomangiomas are most often present in patients with multiple lesions. ( NCI )] (UMLS (CSP) C0334421) =Neoplastic Process
| - 163. glucose 1 phosphate
- [ ] (UMLS (CSP) C0061414) =Carbohydrate; Biologically Active Substance ;
|
- 114. Glomangiomatosis
- [A benign multifocal proliferation of glomus cells forming clusters around dilated vascular spaces. ( NCI )] (UMLS (NCI) C1333824) =Neoplastic Process ;
| - 164. glucose 6 phosphatase
- [An enzyme that catalyzes the conversion of D-glucose 6-phosphate and water to D-glucose and orthophosphate. EC 3.1.3.9. ( MSH )] (UMLS (CSP) C0017755) =Amino Acid, Peptide, or Protein; Enzyme ;
=phosphatase;
|
- 115. Glomangiomyoma
- [A morphologic variant of the glomus tumor with architectural features similar to solid glomus tumor. It is characterized by the presence of elongated glomus cells which resemble mature smooth muscle. ( NCI )] (UMLS (NCI) C0334422) =Neoplastic Process
| - 165. glucose 6 phosphate
- [ester of glucose with phosphoric acid, made in the course of glucose metabolism by mammalian and other cells; a normal constituent of resting muscle and probably in constant equilibrium with fructose-6-phosphate. ( CSP )] (UMLS (CSP) C0061418) =Carbohydrate; Biologically Active Substance ;
=glucose phosphate;
|
- 116. Glomangiosarcoma
- [A very rare morphologic variant of glomus tumor with a size greater than 2 cm. The tumor arises in subfascial or visceral tissues. It characterized by the presence of atypical mitotic figures, or marked nuclear atypia, or the combination of both. It has an aggressive clinical course. ( NCI )] (UMLS (NCI) C1266111) Malignant Glomus Neoplasm;
Malignant Glomus Tumor;
=Neoplastic Process | - 166. glucose 6 phosphate isomerase
- [An enzyme that catalyzes the reversible interconversion of glucose 6-phosphate and fructose 6-phosphate, and is a part of the glycolytic and gluconeogenic pathways. Deficiency of the enzyme, an autosomal recessive trait, results in liver glycogenesis and hemolytic anemia. EC 5.3.1.9. ( MSH )] (UMLS (CSP) C0017759) =Amino Acid, Peptide, or Protein; Enzyme ;
=isomerase;
|
- 117. Glomerular
- [globular tufts of capillaries, one projecting into the expanded end or capsule of each the uriniferous tubules. ( CSP )] (UMLS (NCI) C0022663) =Body Part, Organ, or Organ Component =kidney;
=mesangium;
glomerular visceral epithelial cell | - 167. glucose analog
- [synthetic or natural chemical compounds which resemble naturally occurring glucose in structure and/or function. ( CSP )] (UMLS (CSP) C0596619) =Carbohydrate =analog;
|
- 118. Glomerular Capillary
- (UMLS (NCI) C0226356) =Body Part, Organ, or Organ Component
| - 168. glucose clamp technique
- [technique that maintains a constant blood glucose level by perfusion or infusion with glucose or insulin; used in metabolic rate studies. ( CSP )] (UMLS (CSP) C0017728) =Diagnostic Procedure; Research Activity ;
=diagnostic test;
|
- 119. glomerular endothelium
- [ ] (UMLS (CSP) C0599298) =Body Part, Organ, or Organ Component
| - 169. glucose dehydrogenase
- [D-Glucose:1-oxidoreductases. Catalyzes the oxidation of D-glucose to D-glucono-gamma-lactone and reduced acceptor. Any acceptor except molecular oxygen is permitted. Includes EC 1.1.1.47; EC 1.1.1.118; EC 1.1.1.119 and EC 1.1.99.10. ( MSH )] (UMLS (CSP) C0017730) =Amino Acid, Peptide, or Protein; Enzyme ;
=alcohol oxidoreductase;
|
- 120. glomerular filtration
- [movement and filtering of the plasma-like glomerular filtrate through the glomerular capillaries into the renal tubules. ( CSP )] (UMLS (CSP) C0232809) =Organ or Tissue Function =kidney function;
=glomerular filtration rate;
| - 170. Glucose Intolerance
- [A pathological state in which BLOOD GLUCOSE level is less than approximately 140 mg/100 ml of PLASMA at fasting, and above approximately 200 mg/100 ml plasma at 30-, 60-, or 90-minute during a GLUCOSE TOLERANCE TEST. This condition is seen frequently in DIABETES MELLITUS, but also occurs with other diseases and MALNUTRITION. ( MSH )] (UMLS (NCI) C0271650) =Disease or Syndrome =Carbohydrate Metabolism, Inborn Errors;
|
- 121. glomerular filtration rate
- [rate at which plasma is filtered by the glomerular filtration membrane into Bowman's space; determined by the permeabiliy of the membrane, hydrostatic pressure in the glomerular capillaries and Bowman's space, and the colloid osmotic pressure exerted by the proteins of the capillary plasma. ( CSP )] (UMLS (CSP) C0017654) =Organ or Tissue Function; Diagnostic Procedure =glomerular filtration;
| - 171. glucose metabolism
- [sum of chemical changes that occur within the tissues of an organism consisting of anabolism (biosynthesis) and catabolism of glucose; the buildup and breakdown of glucose for utilization by the organism. ( CSP )] (UMLS (CSP) C0596620) =Molecular Function =carbohydrate metabolism;
=gluconeogenesis;
glycolysis;
hexose monophosphate shunt;
glucose tolerance;
glycogenesis;
glycogenolysis;
|
- 122. glomerular sclerosis
- [fibrosis and scarring of the renal glomeruli involving a part of or the entire glomerulus; can be limited to a small area or can be diffused throughout the entire kidney; caused by diabetic nephropathy, chronic glomerular nephritis, nephrotic syndrome, or renal hypertension. ( CSP )] (UMLS (CSP) C0178664) =Disease or Syndrome ;
=Kidney Disease;
| - 172. glucose monitor
- [ ] (UMLS (CSP) C0872182) =Medical Device ;
|
- 123. Glomerular Vascular Disorder
- (UMLS (NCI) C0852683) =Disease or Syndrome
| - 173. glucose output
- [ ] (UMLS (CSP) C0599782) =Organ or Tissue Function ;
|
- 124. glomerular visceral epithelial cell
- [cells of the visceral epithelium that closely invest the network of glomerular capillaries in the kidney. ( CSP )] (UMLS (CSP) C1328818) Podocyte;
Visceral Epithelial Cell;
visceral glomerular epithelial cell =Cell ;
=Glomerular;
kidney cell | - 174. glucose oxidase
- [An enzyme of the oxidoreductase class that catalyzes the conversion of beta-D-glucose and oxygen to D-glucono-1,5-lactone and peroxide. It is a flavoprotein, highly specific for beta-D-glucose. The enzyme is produced by Penicillium notatum and other fungi and has antibacterial activity in the presence of glucose and oxygen. It is used to estimate glucose concentration in blood or urine samples through the formation of colored dyes by the hydrogen peroxide produced in the reaction. (From Enzyme Nomenclature, 1992) EC 1.1.3.4. ( MSH )] (UMLS (CSP) C0017735) =Amino Acid, Peptide, or Protein; Enzyme ;
=alcohol oxidoreductase;
|
- 125. Glomeruloid Hemangioma
- (UMLS (NCI) C1304511) =Disease or Syndrome
| - 175. glucose phosphate
- [intermediate in carbohydrate metabolism. ( CSP )] (UMLS (CSP) C0017761) =Carbohydrate; Biologically Active Substance ;
=sugar phosphate;
=glucose 6 phosphate |
- 126. glomerulonephritis
- [glomerular disease characterized by an inflammatory reaction, with leukocyte infiltration and cellular proliferation of the glomeruli, or that appears to be the result of immune glomerular injury. ( CSP )] (UMLS (CSP) C0017658) =Disease or Syndrome ;
=autoimmune disease;
nephritis =Bergers disease;
Glomerulonephritis, Membranous;
Lupus Glomerulonephritis;
Anti-Glomerular Basement Membrane Disease;
Bergers disease;
Glomerulonephritis, Membranoproliferative;
Glomerulonephritis, Membranous;
FGS (focal glomerular sclerosis);
Lupus Glomerulonephritis;
Anti-Glomerular Basement Membrane Disease;
| - 176. Glucose Phosphate Isomerase Gene
- [This gene plays a role in glycolysis, gluconeogenesis and energy pathways. ( NCI )] (UMLS (NCI) C1333690) GPI;
GPI Gene;
=Gene or Genome |
- 127. Glomerulonephritis/nephrosis
- (UMLS (ICPC) C0497424) (Glomerulonephritis/nephrosis; GLOMERULONEFRITIA/NEFROSIA; Glumerulonefrit/nefrose; Glomerulonephritis/nefrose; GLOMERULONEFRIITTI/NEFROOSI; Glomerulonephrite/syndr nephr; Glomerulonephritis/Nephrot Syndrom; glomerulonefritis/nefrozis; glomerulonephritis/nephrosis; Glomerulonefrite/nefrosi; GLOMERULONEFRITT/NEFROSE - n00 - n01 - n03 - n04 - n05 - n07 -; Glomerulonefrite/nefrose; Glomerulonefritis/nefrosis; GLOMERULONEFRIT/NEFROS) =Disease or Syndrome =Urologic; Diagnosis/Diseases Component
| - 177. glucose phosphomutase
- [An enzyme that catalyzes the conversion of alpha D-glucose 1-phosphate to alpha D-glucose 6-phosphate. EC 5.4.2.2. ( MSH )] (UMLS (CSP) C0031653) =Amino Acid, Peptide, or Protein; Enzyme ;
=phosphomutase;
|
- 128. Glomus Cell
- (UMLS (NCI) C0229571) =Cell
| - 178. glucose receptor
- [ ] (UMLS (CSP) C0061407) =Amino Acid, Peptide, or Protein; Receptor ;
=carbohydrate receptor;
|
- 129. Glomus Jugulare Neoplasm
- [A benign or malignant extra-adrenal parasympathetic paraganglioma arising from paraganglia in the base of the skull and middle ear. ( NCI )] (UMLS (NCI) C0017671) =Neoplastic Process ;
=Extraadrenal Paraganglioma;
| - 179. glucose sensor
- [ ] (UMLS (CSP) C0872382) =Medical Device ;
◊ [ ] (UMLS (CSP) C1625163) Molecular Function ; |
- 130. Glomus Neoplasm
- [A rare benign or malignant mesenchymal neoplasm arising from cells that resemble the modified smooth muscle cells of the glomus body. The majority of glomus tumors occur in the distal extremities. ( NCI )] (UMLS (NCI) C0017653) =Neoplastic Process =Extraadrenal Paraganglioma;
blood vessel neoplasm | - 180. glucose tolerance
- [physiological ability of the body to properly metabolize glucose. ( CSP )] (UMLS (CSP) C0178665) =Physiologic Function ;
=glucose metabolism;
|
- 131. Glomus Neoplasm of Skin
- [A glomus tumor arising from the skin. It usually presents as a small red-blue nodule and it often associated with pain at the site. ( NCI )] (UMLS (NCI) C0346083) =Neoplastic Process
| - 181. glucose tolerance test
- [oral or intravenous method of assessing the efficiency of an individual to maintain homeostasis of blood glucose, to absorb and store excessive quantities of glucose; includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after intake. ( CSP )] (UMLS (CSP) C0017741) =Diagnostic Procedure =diagnostic test;
|
- 132. Glomus Tumor of Uncertain Malignant Potential
- [A glomus tumor that shows atypical characteristics and has borderline malignant potential. ( NCI )] (UMLS (NCI) C1333826) =Neoplastic Process ;
| - 182. glucose transport
- [movement of glucose through a biological system; can be across cell membranes and epithelial layers and also can occur within intracellular compartments and extracellular compartments. ( CSP )] (UMLS (CSP) C0178666) =Cell Function ;
=carbohydrate transport;
|
- 133. Glossaries
- [Glossary; an alphabetical list of technical terms in some specialized field of knowledge; usually published as an appendix to a text on that field. ( NCI )] (UMLS (NCI) C0681470) =Intellectual Product ;
| - 183. glucose transporter
- [transport protein involved in the uptake of glucose. ( CSP )] (UMLS (CSP) C0017742) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=membrane transport protein;
|
- 134. glossary
- [Refers to a document providing a glossary of terms that pertain to the current document. ( HL7V3.0 )] (UMLS (HL7) C1552855) =Idea or Concept =HtmlLinkType;
| - 184. Glucose Transporter Type 1, Erythrocyte/Brain
- [GLUT1 is an integral membrane glycoprotein involved in transporting glucose into most cells. It is consistently overexpressed in endometrial adenocarcinomas and atypical hyperplasia, but not in typical hyperplasia. Immunostaining for GLUT1 may distinguish benign endometrial hyperplasia from potentially malignant hyperplasia. GLUT1 immunoreactivity in endometrial hyperplasia appears to be a useful indicator of high risk for development of endometrial carcinoma. (from Medscape) ( NCI )] (UMLS (NCI) C1504631) GLUT1 Protein;
HepG2 Glucose Transporter;
SLC2A1;
Solute Carrier Family 2, Facilitated Glucose Transporter, Member 1 =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 135. Glossina
- [ ] (UMLS (CSP) C1011177) =Invertebrate
| - 185. glucose uptake
- [ ] (UMLS (CSP) C0599781) =Organ or Tissue Function ;
|
- 136. Glossinidae
- [family of Diptera occurring only in Africa. ( CSP )] (UMLS (CSP) C0242639) =Invertebrate ;
=Diptera;
| - 186. glucosyltransferase
- [ ] (UMLS (CSP) C0119452) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 137. GLOSSITIS
- [Inflammation of the tongue. ( MSH )] (UMLS (ICD9CM) C0017675) =Disease or Syndrome ;
=Tongue Diseases;
=GEOGRAPHIC TONGUE | - 187. Glucotrol
- (UMLS (NCI) C0701228) =Organic Chemical; Pharmacologic Substance
|
- 138. GLOSSOPHAR NERVE DIS NEC
- [ ] (UMLS (ICD9CM) C0393797) =Disease or Syndrome
| - 188. glucuronate
- [derivatives of uronic acid found throughout the plant and animal kingdoms; they detoxify drugs and toxins by conjugating with them to form glucuronides in the liver which are more water-soluble metabolites that can be easily eliminated from the body. ( CSP )] (UMLS (CSP) C0017774) =Carbohydrate; Biologically Active Substance ;
=hexuronate;
|
- 139. GLOSSOPHARYNG NEURALGIA
- [ ] (UMLS (ICD9CM) C0154731) =Disease or Syndrome
| - 189. glucuronide
- [glycosides of glucuronic acid; their formation is important for the detoxification of drugs, steroid excretion and bilirubin metabolism in forming water-soluble compounds that can be eliminated in the urine and bile. ( CSP )] (UMLS (CSP) C0812407) =Carbohydrate ;
=Glycoside;
|
- 140. Glossopharyngeal Motor Neuropathy
- (UMLS (NCI) C0751942) =Disease or Syndrome ;
| - 190. glucuronosyltransferase
- [A family of enzymes accepting a wide range of substrates, including phenols, alcohols, amines, and fatty acids. They function as drug-metabolizing enzymes that catalyze the conjugation of UDPglucuronic acid to a variety of endogenous and exogenous compounds. EC 2.4.1.17. ( MSH )] (UMLS (CSP) C0041560) =Amino Acid, Peptide, or Protein; Enzyme ;
=hexosyltransferase;
|
- 141. Glossopharyngeal Nerve Neoplasm
- (UMLS (NCI) C1263900) Glossopharyngeal Nerve Neoplasms;
Glossopharyngeal Nerve Tumor;
Glossopharyngeal Nerve Tumors;
IXth Cranial Nerve Neoplasms;
IXth Cranial Nerve Tumors;
Neoplasm of Glossopharyngeal Nerve;
Neoplasm of Ninth Cranial Nerve;
Neoplasm of the Glossopharyngeal Nerve;
Neoplasm of the Ninth Cranial Nerve;
Ninth Cranial Nerve Neoplasm;
Ninth Cranial Nerve Neoplasms;
Ninth Cranial Nerve Tumor;
Ninth Cranial Nerve Tumors;
Tumor of Glossopharyngeal Nerve;
Tumor of Ninth Cranial Nerve;
Tumor of the Glossopharyngeal Nerve;
Tumor of the Ninth Cranial Nerve;
=Neoplastic Process | - 191. glue
- [ ] (UMLS (CSP) C0017780) =Manufactured Object
|
- 142. Glossopharyngeal Nerve Paralysis
- (UMLS (NCI) C0919940) =Disease or Syndrome
| - 192. GLUT 4 protein
- [A glucose transport protein found in mature MUSCLE CELLS and ADIPOCYTES. It promotes transport of glucose from the BLOOD into target TISSUES. The inactive form of the protein is localized in CYTOPLASMIC VESICLES. In response to INSULIN, it is translocated to the PLASMA MEMBRANE where it facilitates glucose uptake. ( MSH )] (UMLS (CSP) C0166441) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 143. Glottic Verrucous Carcinoma
- (UMLS (NCI) C0280329) =Neoplastic Process
| - 193. glutactin
- [ ] (UMLS (CSP) C0598375) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 144. Glottis
- [(GLAH-tis) The middle part of the larynx; the area where the vocal cords are located. ( NCI )] (UMLS (NCI) C0017681) =Body Part, Organ, or Organ Component ;
| - 194. glutamate
- [non-essential amino acid naturally occurring in the L-form; the most common excitatory neurotransmitter in the central nervous system. ( CSP )] (UMLS (CSP) C0017789) =Amino Acid, Peptide, or Protein =Neurotransmitter;
GLUTAMIC ACID;
EAA;
primary aminoacid =Polyglutamic Acid;
|
- 145. Glottis Neoplasm
- (UMLS (NCI) C0345713) =Neoplastic Process
| - 195. glutamate ammonia ligase
- [An enzyme that catalyzes the conversion of ATP, L-glutamate, and NH3 to ADP, orthophosphate, and L-glutamine. It also acts more slowly on 4-methylene-L-glutamate. (From Enzyme Nomenclature, 1992) EC 6.3.1.2. ( MSH )] (UMLS (CSP) C0017801) =Amino Acid, Peptide, or Protein; Enzyme ;
=carbon nitrogen ligase;
|
- 146. GLP
- [Islands in the eastern Caribbean Sea, southeast of Puerto Rico. (NCI) ( NCI )] (UMLS (NCI) C0018301) =Geographic Area ;
| - 196. glutamate decarboxylase
- [A pyridoxal-phosphate protein that catalyzes the alpha-decarboxylation of L-glutamic acid to form gamma-aminobutyric acid and carbon dioxide. The enzyme is found in bacteria and in invertebrate and vertebrate nervous systems. It is the rate-limiting enzyme in determining GAMMA-AMINOBUTYRIC ACID levels in normal nervous tissues. The brain enzyme also acts on L-cysteate, L-cysteine sulfinate, and L-aspartate. EC 4.1.1.15. ( MSH )] (UMLS (CSP) C0017785) =Amino Acid, Peptide, or Protein; Enzyme ;
=carboxy lyase;
|
- 147. GLUC
- [Glucose Plasma Concentration (GPC) measurement is an essential diagnostic modality for different types of carbohydrate metabolism derangements including diabetes mellitus. The disordered carbohydrate metabolism that underlies diabetes manifests as hyperglycemia. Plasma glucose concentrations in healthy individuals vary with age. Normal fasting plasma glucose intervals (in the morning after an overnight fast) in children are 3.3 - 5.6 mmol/L (60-100 mg/dL); adult range - 4.1- 5.9 mmol/L (74-106 mg/dL). GPCs are approximately 11% higher than whole blood if the hematocrit is normal. Glucose concentrations in heparinized plasma are reported to be 5% lower than in serum. ( NCI )] (UMLS (NCI) C0202042) =Laboratory Procedure
| - 197. glutamate dehydrogenase
- [An enzyme that catalyzes the conversion of L-glutamate and water to 2-oxoglutarate and NH3 in the presence of NAD+. (From Enzyme Nomenclature, 1992) EC 1.4.1.2. ( MSH )] (UMLS (CSP) C0017786) =Amino Acid, Peptide, or Protein; Enzyme ;
=amine oxidoreductase;
|
- 148. glucagon like peptide
- [ ] (UMLS (CSP) C0598680) =Amino Acid, Peptide, or Protein ;
| - 198. Glutamate Metabolism
- [The chemical reactions and pathways involving glutamate, the anion of 2-aminopentanedioic acid. [GOC:go_curators] ( GO )] (UMLS (NCI) C1156811) Glutamate Metabolism Pathway;
=Molecular Function |
- 149. glucan
- [group of polysaccharides composed of repeating glucose units; they can consist of branched or unbranched chains in any linkages. ( CSP )] (UMLS (CSP) C0017696) =Carbohydrate =glycan;
hexosan =cellulose;
cyclodextrin;
glycogen;
starch;
DEXTRAN;
cellulose;
Dextrans;
maltose;
starch | - 199. glutamate receptor
- [diverse family of receptors sensitive to glutamate, aspartate, and other acidic aminoacids; subtypes include calcium channels (NMDA), sodium-potassium channels (quisqualate), and a phospholipase C activator (ibotenate). ( CSP )] (UMLS (CSP) C0061465) =Amino Acid, Peptide, or Protein; Receptor ;
=neurotransmitter receptor;
=AMPA receptor;
N methyl D aspartate receptor |
- 150. glucocerebrosidase
- [A glycosidase that hydrolyzes a glucosylceramide to yield free ceramide plus glucose. Deficiency of this enzyme leads to abnormally high concentrations of glucosylceramide in the brain in GAUCHER DISEASE. EC 3.2.1.45. ( MSH )] (UMLS (CSP) C0017768) =Amino Acid, Peptide, or Protein; Enzyme ;
=Glycosylceramidase;
O glycosidase =alglucerase;
Imiglucerase | - 200. Glutamate Receptor, Ionotrophic, AMPA 3 Gene
- [This gene is involved in the regulation of neuronal signal transduction and neurotransmitter activity. ( NCI )] (UMLS (NCI) C1333710) GRIA3;
GRIA3 Gene =Gene or Genome |
home
